Editor's Note This study led by researchers at the Massachusetts General Hospital and Harvard Medical School, Boston, finds that patients who survive serious COVID-19 infections have a long-lasting immune response against the virus. The study includes a cohort of case patients with known COVID-19 infection (343) and controls (1,548). Blood…

Read More

Editor's Note The Joint Commission on October 7 issued a new Quick Safety that focuses on the use of telehealth to deliver patient care while preventing exposure to COVID-19. Other benefits of telehealth in the Quick Safety include: promoting social distancing monitoring the progression of home-quarantined COVID-19 patients enabling providers…

Read More

Editor's Note This study by researchers from Children’s Mercy Hospital, Kansas City, Missouri, and others found that for four economy-sensitive conditions, increased unemployment was associated with increased pediatric hospitalizations. A 1% increase in unemployment was associated with a: 5% increase in hospitalization for substance abuse 4% increase for diabetes 2%…

Read More

Editor's Note David Nabarro, MD, the World Health Organization’s (WHO’s) special envoy on COVID-19 in a video interview on October 10 urged world leaders to stop using lockdowns as their primary COVID-19 control method. He added that WHO believes the only time a lockdown is justified is to buy time…

Read More

Editor's Note In this double-blind, randomized, placebo-controlled study of IV remdesivir in adults hospitalized with COVID-19 and lower respiratory tract infection, remdesivir was found to be superior to placebo in shortening the time to recovery. A total of 1,062 patients were randomized to either remdesivir (541) or placebo (521). Remdesivir…

Read More

Editor's Note The Centers for Medicare & Medicaid Services (CMS) on October 9 announced that it is taking action to stop labs that are testing for COVID-19 without proper Clinical Laboratory Improvements Amendments (CLIA) certification. The agency has issued 171 cease-and-desist letters to US facilities that were testing for COVID-19…

Read More

Editor's Note New research presented October 12 at UEG [United European Gastroenterology] Week Virtual 2020 shows that delays in colorectal cancer (CRC) screening caused by COVID-19 has resulted in significantly increased mortality rates. Researchers at the University of Bologna, Italy, developed a model to forecast the impact of delayed CRC…

Read More

Editor's Note Leandro Pecchia, PhD, associate professor of biomedical engineering at the University of Warwick, Coventry, UK, has been awarded £13 million (nearly $17 million) for the ODIN project. The project will explore the use of robots and artificial intelligence (AI) to ease pressures on hospitals during recovery from COVID-19…

Read More

Editor's Note In this study, funded by the US Department of Veterans Affairs, researchers find that remdesivir probably improves recovery from COVID-19 and reduces serious adverse events and mortality. This analysis of four randomized trials finds that remdesivir compared with placebo may improve recovery (ARD, 7% to 10%), reduce mortality…

Read More

Editor's Note The Centers for Medicare and Medicaid Services (CMS) on October 6 released guidance on how it will implement an interim final rule that requires hospitals and critical access hospitals to report data on COVID-19 and flu patients. CMS says failure to report specified data may lead to termination…

Read More